Gated chimeric antigen receptor T-cells: the next logical step in reducing toxicity?

被引：13

作者：

Davies, David Marc ^{[1
]}

Maher, John ^{[1
,2
]}

机构：

[1] Kings Coll London, Kings Hlth Partners Integrated Canc Ctr, Dept Res Oncol, Guys Hosp Campus, London SE1 9RT, England

[2] Kings Coll Hosp NHS Fdn Trust, Dept Clin Immunol & Allergy, London SE5 9RS, England

来源：

TRANSLATIONAL CANCER RESEARCH | 2016年 / 5卷

关键词：

PROLIFERATION; IMMUNOTHERAPY; ERBB2;

D O I：

10.21037/tcr.2016.06.04

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：S61 / S65

页数：5

共 16 条

[1]

Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia [J].

Davila, Marco L. ;

Riviere, Isabelle ;

Wang, Xiuyan ;

Bartido, Shirley ;

Park, Jae ;

Curran, Kevin ;

Chung, Stephen S. ;

Stefanski, Jolanta ;

Borquez-Ojeda, Oriana ;

Olszewska, Malgorzata ;

Qu, Jinrong ;

Wasielewska, Teresa ;

He, Qing ;

Fink, Mitsu ;

Shinglot, Himaly ;

Youssif, Maher ;

Satter, Mark ;

Wang, Yongzeng ;

Hosey, James ;

Quintanilla, Hilda ;

Halton, Elizabeth ;

Bernal, Yvette ;

Bouhassira, Diana C. G. ;

Arcila, Maria E. ;

Gonen, Mithat ;

Roboz, Gail J. ;

Maslak, Peter ;

Douer, Dan ;

Frattini, Mark G. ;

Giralt, Sergio ;

Sadelain, Michel ;

Brentjens, Renier .

SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (224)

[2]

PD-1-and CTLA-4-Based Inhibitory Chimeric Antigen Receptors (iCARs) Divert Off-Target Immunotherapy Responses [J].

Fedorov, Victor D. ;

Themeli, Maria ;

Sadelain, Michel .

SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (215)

[3]

Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells [J].

Kloss, Christopher C. ;

Condomines, Maud ;

Cartellieri, Marc ;

Bachmann, Michael ;

Sadelain, Michel .

NATURE BIOTECHNOLOGY, 2013, 31 (01) :71-+

[4]

Antigen-dependent CD28 signaling selectively enhances survival and proliferation in genetically modified activated human primary T lymphocytes [J].

Krause, A ;

Guo, HF ;

Latouche, JB ;

Tan, CW ;

Cheung, NKV ;

Sadelain, M .

JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (04) :619-626

[5]

Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity [J].

Lamers, Cor H. J. ;

Sleijfer, Stefan ;

van Steenbergen, Sabine ;

van Elzakker, Pascal ;

van Krimpen, Brigitte ;

Groot, Corrien ;

Vulto, Arnold ;

den Bakker, Michael ;

Oosterwijk, Egbert ;

Debets, Reno ;

Gratama, Jan W. .

MOLECULAR THERAPY, 2013, 21 (04) :904-912

[6]

Chimeric Antigen Receptor T Cells with Dissociated Signaling Domains Exhibit Focused Antitumor Activity with Reduced Potential for Toxicity In Vivo [J].

Lanitis, Evripidis ;

Poussin, Mathilde ;

Klattenhoff, Alex W. ;

Song, Degang ;

Sandaltzopoulos, Raphael ;

June, Carl H. ;

Powell, Daniel J., Jr. .

CANCER IMMUNOLOGY RESEARCH, 2013, 1 (01) :43-53

[7]

T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial [J].

Lee, Daniel W. ;

Kochenderfer, James N. ;

Stetler-Stevenson, Maryalice ;

Cui, Yongzhi K. ;

Delbrook, Cindy ;

Feldman, Steven A. ;

Fry, Terry J. ;

Orentas, Rimas ;

Sabatino, Marianna ;

Shah, Nirali N. ;

Steinberg, Seth M. ;

Stroncek, Dave ;

Tschemia, Nick ;

Yuan, Constance ;

Zhang, Hua ;

Zhang, Ling ;

Rosenberg, Steven A. ;

Wayne, Alan S. ;

Mackall, Crystal L. .

LANCET, 2015, 385 (9967) :517-528

[8]

Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ/CD28 receptor [J].

Maher, J ;

Brentjens, RJ ;

Gunset, G ;

Rivière, I ;

Sadelain, M .

NATURE BIOTECHNOLOGY, 2002, 20 (01) :70-75

[9]

Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia [J].

Maude, Shannon L. ;

Frey, Noelle ;

Shaw, Pamela A. ;

Aplenc, Richard ;

Barrett, David M. ;

Bunin, Nancy J. ;

Chew, Anne ;

Gonzalez, Vanessa E. ;

Zheng, Zhaohui ;

Lacey, Simon F. ;

Mahnke, Yolanda D. ;

Melenhorst, Jan J. ;

Rheingold, Susan R. ;

Shen, Angela ;

Teachey, David T. ;

Levine, Bruce L. ;

June, Carl H. ;

Porter, David L. ;

Grupp, Stephan A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (16) :1507-1517

[10]

Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2 [J].

Morgan, Richard A. ;

Yang, James C. ;

Kitano, Mio ;

Dudley, Mark E. ;

Laurencot, Carolyn M. ;

Rosenberg, Steven A. .

MOLECULAR THERAPY, 2010, 18 (04) :843-851

← 1 2 →